List of Contents

Population Health Management Market Size, Share, and Trends 2024 to 2034

The global population health management market size is calculated at USD 42.95 billion in 2025 and is forecasted to reach around USD 186.17 billion by 2034, accelerating at a CAGR of 17.7% from 2025 to 2034. The North America market size surpassed USD 17.15 billion in 2024 and is expanding at a CAGR of 17.74% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : January 2025
  • Report Code : 1091
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Population Health Management Market, By Product

7.1. Population Health Management Market, by Product Type, 2025-2034
7.1.1. Services
7.1.1.1. Market Revenue and Forecast (2022-2034)
7.1.2. Software
7.1.2.1. Market Revenue and Forecast (2022-2034)

Chapter 8. Global Population Health Management Market, By Application

8.1. Population Health Management Market, by Application, 2025-2034
8.1.1. Providers
8.1.1.1. Market Revenue and Forecast (2022-2034)
8.1.2. Payers
8.1.2.1. Market Revenue and Forecast (2022-2034)
8.1.3. Employer Group
8.1.3.1. Market Revenue and Forecast (2022-2034)

Chapter 9. Global Population Health Management Market, Regional Estimates and Trend Forecast

9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2022-2034)
9.1.2. Market Revenue and Forecast, by Application (2022-2034)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.1.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.1.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.2. Market Revenue and Forecast, by Application (2022-2034)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.5.2. Market Revenue and Forecast, by Application (2022-2034)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.6.2. Market Revenue and Forecast, by Application (2022-2034)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.5.2. Market Revenue and Forecast, by Application (2022-2034)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.6.2. Market Revenue and Forecast, by Application (2022-2034)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.5.2. Market Revenue and Forecast, by Application (2022-2034)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.6.2. Market Revenue and Forecast, by Application (2022-2034)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2022-2034)
9.5.2. Market Revenue and Forecast, by Application (2022-2034)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.5.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.5.4.2. Market Revenue and Forecast, by Application (2022-2034)

Chapter 10. Company Profiles

10.1. Cerner Corporation
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Allscripts Healthcare, LLC
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Conifer Health Solutions, LLC
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Enli Health Intelligence
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. eClinicalWorks
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. McKesson Corporation
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Optum, Inc.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Medecision
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Advisory Board
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Athenahealth, Inc.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Koninklijke Philips N.V.
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
10.12. Welltok
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives
10.13. RedBrick Health Corporation
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global population health management market size was valued at around USD 36.49 billion in 2024 and is expected to reach over USD 186.17 billion by 2034.

The global population health management market is anticipated to grow at a CAGR of 17.7% during the forecast period 2025 to 2034.

Government support and mandates for healthcare IT solutions, the need to curtail the escalating healthcare costs,and increasing use of big data analytics are the key factors that drive the market growth. In addition, increasing digitalization of healthcare systems, rising geriatric population coupled with burden of chronic diseases, and the increasing requirement for affordable treatment options because of rising healthcare costs are the other most prime factors that contribute positively towards the growth of the market.

Some of the key players operating in the market are Cerner Corporation, Allscripts Healthcare, LLC, Conifer Health Solutions, LLC, Enli Health Intelligence, eClinicalWorks, McKesson Corporation, Optum, Inc., Medecision, Advisory Board, Athenahealth, Inc., Koninklijke Philips N.V., Welltok, and RedBrick Health Corporation among others.

North America led the global market in terms of revenue share in 2023 because of an alarming increase in the healthcare costs.

The Asia Pacific PHM market anticipated to exhibits the fastest growth rate over the forecast period due to rising healthcare expenditure along with improving healthcare infrastructure.

On the basis of product, services segment held the largest market share as hospitals and other care providers prefer in-house solution & system.

By end-use segment, healthcare providers captured the maximum value share in the market in 2023 due to significant outcome from medical centers and clinics.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us